NeOnc Technologies Holdings, Inc. (NTHI)

NeOnc Technologies Holdings will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$11.25 - $13.75
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 282.00M
Revenue (ttm) 90,462
Net Income (ttm) -9.83M
Shares Out 22.56M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About NTHI

NeOnc Technologies (f/k/a NAS-ONC, Inc.) was formed in 2008, devoted to developing new drugs with new delivery modes. As a clinical-stage biopharmaceutical company, we have focused on establishing treatments for intracranial malignancies, i.e., aggressive cancers located in the brain. These cancer types include primary brain cancers, such as glioblastoma, and secondary brain cancers, that have arrived through metastatic spread from other cancers throughout the body, such as melanoma or breast and lung cancer. Brain-localized malignancies are pa... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 8
Stock Exchange NASDAQ
Ticker Symbol NTHI
Full Company Profile

Financial Performance

Financial Statements


NeOnc Technologies IPO Registration Document (S-1)

NeOnc Technologies has filed to go public with an IPO on the NASDAQ.

4 months ago - SEC